Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

糠酸莫米松鼻喷雾剂 - NMPA Drug Approval Details

Approvals/NMPA/Mometasone Furoate Nasal Spray

Approved

化学药品

Mometasone Furoate Nasal Spray

Lek Pharmaceuticals dd🇨🇳 National Medical Products Administration

Approval Date: Nov 15, 2022
Approval ID: efcbd3ddec741fb1
Company: Lek Pharmaceuticals dd
Type: 化学药品

Approval Details

Approval Id: efcbd3ddec741fb1
Approval Number: 国药准字HJ20220085
Generic Name: 糠酸莫米松鼻喷雾剂
Generic Name En: Mometasone Furoate Nasal Spray
Drug Type: 化学药品
Dosage Form: 鼻用制剂
Strength: 每瓶140揿，每揿含糠酸莫米松50μg，药物浓度为0.05%（g/g）
Reg Date: 2022-11-15
Expired Date: 2027-11-14
Company Name: Lek Pharmaceuticals dd
Production Company Name: Lek Pharmaceuticals dd
Company Detail Path: /organization/lek-pharmaceuticals-dd
Production Company Detail Path: /organization/lek-pharmaceuticals-dd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Nov 15, 2022

Approval ID

efcbd3ddec741fb1

Type

化学药品

Back to NMPA Approvals